HEALIUS LIMITED — Director's Dealing 2015

Mar 5, 2015

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	PRIMARY HEALTH CARE LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Edmund Gregory Thomas Bateman
Date of last notice	11 December 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	As shown
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest.	As shown
Date of change	a) 2 March 2015b) 3 March 2015c) 4 March 2015d) 5 March 2015
No. of securities held prior tochange	506,483Abtourk (Syd No.391) Pty Ltd17,413,251Idameneo (No. 122) Pty Ltd104,836Belinda Carwardine Bateman andEdmund Gregory Thomas Bateman180,000Belinda Carwardine Bateman 756,258 Dr Edmund Bateman18,960,828Ordinary shares
Class	Fully paid ordinary shares
Number acquired	Not applicable
Number disposed	4,225,000

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation	a) 2,000,000 at $4.81 per shareb) 1,000,000 at $4.86 per sharec) 1,000,000 at $4.93 per shared) 225,000 at $4.95 per share
No. of securities held afterchange	506,483Abtourk (Syd No.391) Pty Ltd13,188,251Idameneo (No. 122) Pty Ltd104,836Belinda Carwardine Bateman andEdmund Gregory Thomas Bateman180,000Belinda Carwardine Bateman 756,258 Dr Edmund Bateman14,735,828Ordinary shares
Nature of changeExample:on-markettrade,off-markettrade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back	On-market trades

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not applicable
Nature of interest	Not applicable
Name of registered holder(if issued securities)	Not applicable
Date of change	Not applicable
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract inrelation to which the interest has changed	Not applicable
Interest acquired	Not applicable
Interest disposed	Not applicable
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	Not applicable
Interest after change	Not applicable

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period where**prior written clearance was required? **	Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period?	Not applicable
If prior written clearance was provided, on what datewas this provided?	Not applicable

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011